首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   203469篇
  免费   16454篇
  国内免费   600篇
耳鼻咽喉   2682篇
儿科学   5639篇
妇产科学   3797篇
基础医学   27352篇
口腔科学   4335篇
临床医学   22430篇
内科学   40255篇
皮肤病学   3170篇
神经病学   18464篇
特种医学   6946篇
外国民族医学   14篇
外科学   28936篇
综合类   3510篇
现状与发展   1篇
一般理论   231篇
预防医学   20180篇
眼科学   4708篇
药学   15006篇
  3篇
中国医学   249篇
肿瘤学   12615篇
  2022年   1341篇
  2021年   3104篇
  2020年   1923篇
  2019年   3079篇
  2018年   3635篇
  2017年   2734篇
  2016年   2980篇
  2015年   3570篇
  2014年   4957篇
  2013年   7723篇
  2012年   11014篇
  2011年   11752篇
  2010年   6549篇
  2009年   6279篇
  2008年   10994篇
  2007年   11818篇
  2006年   11531篇
  2005年   11884篇
  2004年   11169篇
  2003年   10774篇
  2002年   10302篇
  2001年   3854篇
  2000年   3716篇
  1999年   3672篇
  1998年   2701篇
  1997年   2260篇
  1996年   2002篇
  1995年   1897篇
  1994年   1722篇
  1993年   1664篇
  1992年   2836篇
  1991年   2709篇
  1990年   2556篇
  1989年   2471篇
  1988年   2329篇
  1987年   2305篇
  1986年   2216篇
  1985年   2314篇
  1984年   2203篇
  1983年   2068篇
  1982年   1973篇
  1981年   1745篇
  1980年   1564篇
  1979年   1668篇
  1978年   1434篇
  1977年   1296篇
  1976年   1155篇
  1975年   1114篇
  1974年   1216篇
  1973年   1045篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome.  相似文献   
2.
3.
4.
5.
6.
7.
8.
9.

Background

Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.

Methods

Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.

Results

Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).

Conclusions

Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF.  相似文献   
10.
Context: Persons with spinal cord injury (SCI) experience significant challenges when they access primary care and community services.

Design: A provincial summit was held to direct research, education, and innovation for primary and community care for SCI.

Setting: Toronto, Ontario, Canada.

Participants: Key stakeholders (N?=?95) including persons with SCI and caregivers, clinicians from primary care, rehabilitation, and specialized care, researchers, advocacy groups, and policy makers.

Methods: A one-day facilitated meeting that included guest speakers, panel discussions and small group discussions was held to generate potential solutions to current issues related to SCI care and to foster collaborative relationships to advance care for SCI. Perspectives on SCI management were shared by primary care, neurosurgery, rehabilitation, and members of the SCI community

Outcome Measures: Discussions were focused on five domains: knowledge translation and dissemination, application of best practices, communication, research, and patient service accessibility.

Results: Summit participants identified issues and prioritized solutions to improve primary and community care including the creation of a network of key stakeholders to enable knowledge creation and dissemination; an online repository of SCI resources, integrated health records, and a clinical network for SCI care; development and implementation of strategies to improve care transitions across sectors; implementation of effective care models and improved access to services; and utilization of empowerment frameworks to support self-management.

Conclusions: This summit identified priorities for further collaborative efforts to advance SCI primary and community care and will inform the development of a provincial SCI strategy aimed at improving the system of care for SCI.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号